Related Experiment Video
Updated: Oct 11, 2025

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
Published on: November 19, 2014
Electrocardiographic abnormalities and psychotropic polypharmacy in schizophrenia and schizoaffective disorders
Srinivasan Tirupati1, Sachal Gulati2
1Psychiatric Rehabilitation Service, Hunter New England Mental Health, Morisset, NSW, Australia; and School of Public Health and Medicine, Faculty of Health, The University of Newcastle, Callaghan, NSW, Australia.
Insights
Sudden cardiac death is a risk for schizophrenia patients. Many patients have electrocardiogram (ECG) abnormalities, not just prolonged QTc, indicating potential arrhythmia risks needing evaluation.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Sudden cardiac death (SCD) is a major cause of mortality in individuals with schizophrenia and schizoaffective disorders.
- Cardiac arrhythmias are a known cause of SCD, and electrocardiogram (ECG) abnormalities can predict these arrhythmias.
- Antipsychotic drug use has been linked to ECG abnormalities.
Purpose of the Study:
- To examine the types and frequency of ECG abnormalities (ECG-Abs) in patients with schizophrenia and schizoaffective disorder.
- To investigate the association of ECG-Abs with demographic factors and psychotropic drug prescriptions.
Main Methods:
- A chart audit was conducted on 169 patients in a long-stay inpatient unit.
- Statistical analyses included chi-square test, Fisher's Exact test, independent two-sample t-test, Pearson's correlation, and one-way ANOVA.
- ECG abnormalities were assessed in relation to demographic details and psychotropic medication.
Main Results:
- Over half of the patients (52.1%) exhibited at least one ECG abnormality.
- A significant portion (20.7%) had two or more ECG abnormalities.
- The use of multiple antipsychotics, with or without other psychotropic drugs, did not show a significant association with the presence or number of ECG abnormalities.
Conclusions:
- A substantial number of patients with schizophrenia and schizoaffective disorder present with ECG abnormalities beyond prolonged QTc interval, potentially predisposing them to cardiac arrhythmias.
- These ECG abnormalities are not exclusive to patients on psychotropic polypharmacy.
- Comprehensive ECG evaluation is recommended for all patients to identify arrhythmia risk, considering a range of electrical abnormalities.
Background:
Sudden cardiac death (SCD) is a significant cause for increased mortality in people with schizophrenia and schizoaffective disorders. Cardiac arrhythmia is one cause of SCD. Electrocardiographic (ECG) abnormalities predictive of arrhythmias are associated with antipsychotic drug use.
Method:
This chart audit examined the types and frequency of ECG abnormalities (ECG-Abs) in 169 patients with schizophrenia and schizoaffective disorder in a long-stay inpatient unit. We examined the association of ECG-Abs with demographic details and psychotropic drug prescription using chi-square test, Fisher's Exact test, independent two-sample t-test, Pearson's correlation, and one-way ANOVA.
Results:
Eighty-eight patients (52.1%) recorded at least one ECG-Ab, and 20.7% had two or more ECG-Abs. The use of multiple antipsychotics, with or without other psychotropic drugs, did not associate significantly with the presence or number of ECG-Abs.
Conclusion:
A significant proportion of patients with schizophrenia and schizoaffective disorder have ECG-Abs other than prolonged QTc interval, which can predispose them to cardiac arrhythmias. The abnormalities were not limited to patients on psychotropic polypharmacy. ECG evaluation is indicated for all patients and should consider various electrical abnormalities to identify arrhythmia risk.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Mania and Antimanic Drugs: Overview
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

